We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Issues Long-Awaited Final Rule On De Novo Device Classification
FDA Issues Long-Awaited Final Rule On De Novo Device Classification
After three years, the FDA has published the final version of its proposed rule on De Novo device classification, which offers a pathway for marketing authorization for new Class I and Class II De Novo devices instead of automatically designating them as high-risk Class III devices.